OptiBiotix launches WellBiome for digestive, cardiovascular, metabolic health

August 14, 2020
Alissa Marrapodi

UK-based OptiBiotix Health PLC launched WellBiome, a functional fiber and mineral blend, containing fructooligosaccharides, glucomannan, and chromium.

UK-based OptiBiotix Health PLC launched WellBiome, a functional fiber and mineral blend, containing fructooligosaccharides, glucomannan, and chromium, formulated to support the growth of beneficial bacteria and improve overall wellbeing. It was developed by UK universities and key opinion leaders on the gut microbiome and functional food ingredients, and it is gluten- and lactose-free.

“We are pleased to unveil our new revolutionary ingredient that joins the OptiBiotix ingredients portfolio,” said Frederic Narbel, DBA, managing director of functional fibers at OptiBiotix, in a press release. “As consumer awareness of the gut microbiome increases, products that contain functional fibers that support health and wellbeing are becoming increasingly popular. With the microbiome modulating WellBiome, our partners can now extend their reach into the exciting health and wellbeing market with a science-backed offering.”

WellBiome’s patented formulation has shown its efficacy in controlled human studies. The prebiotic helps to maintain a healthy digestive system and supports regular bowel habits by significantly increasing essential bacteria, including the Bifidobacterium, Bacteroides, and Christensenella strains due to its high soluble fiber content (94%). In addition, scientific studies have demonstrated WellBiome can regulate glycemic response to support metabolic health and significantly reduce systolic blood pressure. It also supports several European Food Safety Authority (EFSA) health claims, including the use of chromium which contributes to the maintenance of normal blood glucose levels and glucomannan, which reduces blood cholesterol.

“The Health and Wellness industry is estimated to be worth $4.2 trillion in 2019, with the digestive health segment accounting for $60 billion,” said Narbel. “For OptiBiotix, the development of WellBiome is a direct response to the trends that are dominating the industry today. As a leading life sciences company that excels in delivering science-backed ingredients, we are helping to combat the health challenges of today, tomorrow and the near future. WellBiome is a major part of this journey and will help play a key role in the livelihoods of consumers by improving digestive, heart and metabolic health.”